Found: 12
Select item for more details and to access through your institution.
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): I. Direct inhibition of O<sup>6</sup>-alkylguanine-DNA alkyltransferase (AGT) by electrophilic species generated by decomposition.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 279, doi. 10.1007/s00280-003-0740-7
- By:
- Publication type:
- Article
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O<sup>6</sup>-alkylguanine-DNA alkyltransferase in cytotoxicity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 288
- By:
- Publication type:
- Article
The efficacy of the combination therapy of 5-fluorouracil, cisplatin and leucovorin for hepatocellular carcinoma and its predictable factors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 296
- By:
- Publication type:
- Article
Comparison of four modulators of drug metabolism as protectants against the hepatotoxicity of the novel antitumor drug yondelis (ET-743) in the female rat and in hepatocytes in vitro.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 313, doi. 10.1007/s00280-003-0741-6
- By:
- Publication type:
- Article
The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimen.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 329, doi. 10.1007/s00280-003-0719-4
- By:
- Publication type:
- Article
Phase II clinical trial of parenteral hydroxyurea in combination with fluorouracil, interferon and filgrastim in the treatment of advanced pancreatic, gastric and neuroendocrine tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 337, doi. 10.1007/s00280-003-0727-4
- By:
- Publication type:
- Article
A cancer research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 349, doi. 10.1007/s00280-003-0742-5
- By:
- Publication type:
- Article
Phase I trial of the antifolate ZD9331 in combination with cisplatin in patients with refractory solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 357, doi. 10.1007/s00280-003-0735-4
- By:
- Publication type:
- Article
Acknowledgement to Reviewers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 361, doi. 10.1007/s00280-004-0785-2
- Publication type:
- Article